Simpo, Wena Mae L.
HRN: 20-05-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2026
CEFTRIAXONE 1G (VIAL)
02/20/2026
02/27/2026
IV
2g
OD
CAP
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: